United Therapeutics Corporation (UTHR)
NASDAQ·Healthcare·Biotechnology
$494.72
-0.51%
Mkt Cap $21.10B
Analyst Ratings
Buy
7
Hold
5
Sell
0
Price Target (38 analysts)
$636.83
Range $516.00 – $735.00
Implied Upside
+28.7%
Consensus $636.83 vs current $494.72